Science and Technology Minister Dr. Jitendra Singh inaugurates the 4th Edition of the Global Bio India 2024.
“As India emerges as a global biotech powerhouse, Prime Minister Narendra Modi will be hailed across the world as the champion of the new biotech boom,” says union minister Dr. Jitendra Singh.
‘India Bio Economy Report 2024’ unveiled at the Global Bio India
BIRAC signs 9 Letters of Intent with leading international organizations.
“Global Bio India 2024: Spotlight on New Startups, Global Partnerships, and Cutting-Edge Innovations”
PIB, September 12, 2024: “Global Bio India Unveils 30 Breakthrough Startups, Paving the Way for the Future of Biotech,” says Union Minister Dr. Jitendra Singh at the inaugural ceremony of Global Bio India 2024 here today at Pragati Maidan.
Addressing the inaugural ceremony of the Global Bio India Conference, Union Minister of State (Independent Charge) for Science and Technology, Minister of State (Independent Charge) for Earth Sciences, MoS PMO, Department of Atomic Energy and Department of Space, MoS Personnel, Public Grievances and Pensions, Dr. Jitendra Singh congratulated DBT and BIRAC for enabling the phenomenal growth and said India’s bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030.
As India emerges as a global biotech powerhouse, said Dr. Jitendra Singh, Prime Minister Narendra Modi will be hailed across the world as the champion of the new biotech boom, which promises to boost the economy, innovation, jobs, and environmental commitments.
Dr. Jitendra Singh highlighted the ‘India Bio Economy Report 2024’ brought out by the Department of Biotechnology and BIRAC that captures the phenomenal progress made by the Indian biotech industry. He hailed the visionary leadership of Prime Minister Shri. Narendra Modi guiding us in this new era of biotechnology transformation.
Highlighting the importance of Global Bio-India, Dr. Jitendra Singh said, “GBI offers a unique business networking platform for varied participants, including central and state ministries, startups, SMEs, large industries, bioclusters, research institutes, investors, incubators, regulators, policymakers, business analysts, legal, IP, CROs, innovation missions from other countries, international bodies, and industry associations.”.
Tracing the journey, he lauded the DBT-BIRAC for successfully organizing three editions of Global Bio-India. He also recalled that the first Startup Expo for the Biotech Sector was also organized in June 2022, which was inaugurated by Prime Minister Shri Narendra Modi.
Dr. Jitendra Singh called the Global Bio-India 2024 a much bigger event as compared to 2023, with participation from 30+ countries, 500+ exhibitors, 5000+ delegates, 1000+ startups, B2B, B2G, G2G meetings, and much more. Dr. Singh said, “There are a billion reasons to invest in India, the reasons being India has a 60% share of global vaccine production and has the 2nd highest number of USFDA-approved manufacturing plants outside the USA. Opportunities for investments are available in Bio-Pharma, Bio-Agri, Bio-Industrial, Bio-energy, Bio-Services, and Med-Tech.”
Underscoring that “bio-revolution” in India is synonymous with the IT revolution driven by the western world, Dr. Jitendra categorically mentioned the BioE3 (Biotechnology for Economy, Employment, and Environment) policy recently approved by the Union Cabinet under the leadership of PM Modi.
Sharing details on the BioE3 Policy, he called this policy the timely intervention at this crucial juncture for our country in the back drop of global climate change to enable the creation of a cleaner, greener, and prosperous India. He expressed confidence that the new policy would contribute significantly to the global economy while protecting our environment.
He also reiterated the key areas of focus such as bio-based chemicals and enzymes, smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and utilization, and advanced marine and space research. Dr. Jitendra Singh referred to these as the future of biotechnology and drive growth and innovation across various industries.
The BioE3 Policy will support this transformation by establishing cutting-edge biomanufacturing facilities, biofoundry clusters, and bio-AI hubs. The biotech hubs will bridge the gap between research and commercial manufacturing, fostering collaboration between startups, SMEs, and established companies, thereby boosting high-performance biomanufacturing and the bioeconomy. Integration of AI to analyze large-scale biological data will pave the way for advancements in gene therapies and food processing, added the minister.
Emphasizing the employment opportunities being created, particularly in Tier II and Tier III cities, he stated that biomanufacturing hubs will use local resources and contribute to regional economic development, promoting more inclusive growth.
Dr. Jitendra Singh gave the clarion call to raise the bar, break barriers, and reach new heights. He said, “With the momentum we’ve gained and the convergence of talent, India@ 2047 will be a biotechnology leader.
The Biotechnology Industry Research Assistance Council (BIRAC) signed a Letter of Intent with nine leading international organizations in biotechnology, namely
- United States Pharmacopeial Convention (USP)
- UK Research and Innovation (UKRI), UK
- DHR Holding India Pvt. Ltd. (Danaher)
- Mauritius Institute of Biotechnology Ltd. (MIBL)
- La Trobe University
- Blockchain for Impact (BFI)
- US-India Strategic Partnership Forum (USISPF)
- IBioM (Indian Biotech MSME and Startup Foundation)
- Bharat Startup and Innovation Society (BSIS)—Bharat Startup Festival
The Indian Bio Economy Report 2024 was also launched at the Global Bio India 2024 along with the BIRAC Compendium of Products and Technologies 2024. In addition to this, the event also witnessed the launch of the GBI Exhibitor Directory, coupled with insights into the BIRAC Equity Fund and the Amrit Grand Challenge JanCARE Innovations Report.
Dr. Kiran Mazumdar Shaw, Executive Chairperson, Biocon Limited, called for enhanced cooperation and collaboration to increase market share and volume of India’s pharmaceutical sector. He also said, “Biology will drive economic growth in the future economy by leveraging innovation, investment, intellectual property, and sustainable growth.
Dr. Tina Sejersgard Fano, Executive Vice President, Planetary Health BioSolutions, Novonesis, thanked India for the BioE3 policy and said, “We need solutions for the economy as well as the environment.”
Prof. Ajay Kumar Sood, Principal Scientific Adviser, Government of India, quoted the ‘Australian Strategic Pacific Institute ASPI’ report and said India is among the top countries in 45 out of 64 technologies as per the report and in 2nd position in biotech manufacturing.
Dr. Rajesh S. Gokhale, Secretary, Department of Biotechnology, Chairman, BIRAC, and DG-iBRIC, highlighted the pivotal role of such an international conference. Dr. (Mrs.) N. Kalaiselvi, DG, CSIR, called this the decade of innovation and research; Mr. G. S. Krishnan, President, Association of Biotech Led Enterprises; and Dr. Jitendra Kumar, Managing Director, BIRAC, were also present at the inaugural ceremony.
Also read: Unveiling the Ethical Imperatives: Navigating the Intersection of AI and Cybersecurity
Do Follow: CIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter
About us:
CIO News is the premier platform dedicated to delivering the latest news, updates, and insights from the CIO industry. As a trusted source in the technology and IT sector, we provide a comprehensive resource for executives and professionals seeking to stay informed and ahead of the curve. With a focus on cutting-edge developments and trends, CIO News serves as your go-to destination for staying abreast of the rapidly evolving landscape of technology and IT. Founded in June 2020, CIO News has rapidly evolved with ambitious growth plans to expand globally, targeting markets in the Middle East & Africa, ASEAN, USA, and the UK.
CIO News is a proprietary of Mercadeo Multiventures Pvt Ltd.
